Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study.
Ontology highlight
ABSTRACT: Risperidone and aripiprazole are approved by the USA Food and Drug Administration for the treatment of irritability and aggression in children from the ages of 5 and 6 years, respectively. However, there are no approved medications for the treatment of autism spectrum disorder (ASD) core signs and symptoms. Nevertheless, early intervention is recognized as key to improving long-term outcomes. This retrospective case study included 10 children (mean age, 2 years 10 months) with ASD who presented with persistent irritability and aggression before 4 years of age that was unresponsive to behavioral interventions and sufficiently severe to consider pharmacological intervention with risperidone or aripiprazole combined with standard supportive therapies. Besides ameliorating comorbid behaviors,
SUBMITTER: Alsayouf HA
PROVIDER: S-EPMC8143447 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA